Mary Crowley Cancer Research - Medical City — Dallas, Texas

Mary Crowley Cancer Research - Medical City is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Mary Crowley Cancer Research - Medical City has participated in 4 clinical trials.

Therapeutic areas: Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors.

Sponsors: Taiho Oncology, Inc., Xencor, Inc., Aduro Biotech, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mary Crowley Cancer Research - Medical City?

Mary Crowley Cancer Research - Medical City has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mary Crowley Cancer Research - Medical City conducted?

Mary Crowley Cancer Research - Medical City has 4 clinical trials on record. Their work covers Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors.

Is Mary Crowley Cancer Research - Medical City accredited by Crixeo Clinical Trials?

Mary Crowley Cancer Research - Medical City has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mary Crowley Cancer Research - Medical City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.